EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CRDF: Cardiff Oncology Inc

24 Oct 25 15:59
LAST:

2.225

CHANGE:
 0.02		OPEN:
2.220		HIGH:
2.250		ASK:
0.000		VOLUME:
702.6K
CHG(%):
0.90		PREV:
2.210		LOW:
2.185		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Oct 252.2202.2502.1852.230787.8K
23 Oct 252.1502.2402.1502.210471.0K
22 Oct 252.2202.2302.1002.160689.9K
21 Oct 252.2502.2702.1602.230771.4K
20 Oct 252.2402.3302.2202.280889.0K
17 Oct 252.2402.2552.1602.190781.5K
16 Oct 252.4002.4302.2352.240810.4K
15 Oct 252.2902.4602.2902.4101.37M
14 Oct 252.2502.2902.2002.270552.2K
13 Oct 252.2402.2802.2202.260381.5K

COMPANY PROFILE

Name:Cardiff Oncology Inc
About:Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated ongoing or planned trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, and triple negative breast cancer; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with SoC FOLFIRI and bevacizumab or SoC FOLFOX and bevacizumab for the first-line treatment of patients with RAS-mutated mCRC; TROV-054, a Phase 1b/2 open-label multi-center clinical trial of onvansertib in combination with SoC FOLFIRI and bevacizumab for the second-line treatment of patients with KRAS-mutated mCRC; and CRDF-001, a Phase 2 open-label multi-center clinical trial of onvansertib in combination with nanoliposomal irinotecan leucovorin, and fluorouracil for second line treatment of patients with mPDAC. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:11055 Flintkote Avenue, San Diego, CA, United States, 92121
Website:https://www.cardiffoncology.com
CUSIP:98410V109
CIK:0001213037
ISIN:US14147L1089
FIGI:BBG000PXLKM7
LEI:549300AHOLZBHHYFWP04

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:2.220.1%
MA10:2.251.0%
MA20:2.220.2%
MA50:2.172.6%
MA100:2.8025.8%
MA200:3.1240.3%
STO9:23.33
STO14:22.58
RSI14:51.43
WPR14:-72.00
MTM14:-0.01
ROC14:0.00 
ATR:0.13 
Week High:2.334.7%
Week Low:2.106.0%
Month High:2.4711.0%
Month Low:1.9640.3%
Year High:5.64153.5%
Year Low:1.9017.1%
Volatility:28.62 

RECENT SPLITS

Date Ratio
20 Feb 20191-6
04 Jun 20181-12
30 May 20121-6
27 Jul 2004111-1